10/30/2020  9:10:00 PM Chg. +18.39 Volume Bid12:09:58 AM Ask10/30/2020 Market Capitalization Dividend Y. P/E Ratio
586.42USD +3.24% 234,986
Turnover: 78.55 mill.
587.00Bid Size: 100 680.71Ask Size: 100 14.51 bill.USD 0.00% 9.95

Business description

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations.
 

Management board & Supervisory board

CEO
Norman Schwartz
Management board
Ilan Daskal, Ajit Ramalingam, Annette Tumolo, Dara Wright, Dr. Andrew J. Last, Giovanni Magni, Mike Crowley, Ronald W. Hutton, Timothy S. Ernst
Supervisory board
Norman Schwartz, Alice N. Schwartz, Arnold Pinkston, Gregory Hinckley, Jeffrey Edwards, Melinda Litherland
 

Company data

Name: Bio-Rad Laboratories Inc.
Address: 1000 Alfred Nobel Drive,Hercules, California 94547, USA
Phone: +1-510-741-7000
Fax: +1-510-741-5817
E-mail: -
Internet: www.bio-rad.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 82.70%
IPO date: -

Investor relations

Name: Kevin Han
IR phone: +1-510-741-6777
IR Fax: -
IR e-mail: ir@bio-rad.com

Main Shareholders

Freefloat
 
82.70%
BlackRock, Inc.
 
9.30%
The Vanguard Group, Inc.
 
8.00%